Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q4 2018 13F Portfolio Holders as of 12/31/2018

Type / Class
Equity / COM STK CL A
Number of holders
157
Total Shares
116M
Shares change
+7.67M
Total reported value, excl. options
$1.57B
Value change
+$89.7M
Put/Call ratio
0
Number of buys
63
Number of sells
-87
Price
$13.53
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.